Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

2052 ARTÍCULOS , VIENDO DEL 61 AL 75

Impact of 40 Hz Transcranial Alternating Current Stimulation on Cerebral Tau Burden in Patients with Alzheimer's Disease: A Case Series

Dhaynaut M, Sprugnoli G, Cappon D, Macone J, Sanchez JS, Normandin MD, Guehl NJ, Koch G, Paciorek R, Connor A, Press D, Johnson K, Pascual-Leone A, El Fakhri G, Santarnecchi E.

J Alzheimers Dis. 2022;85(4):1667-1676. doi: 10.3233/JAD-215072.

Alzheimer's Disease: A Decreased Cerebral Blood Flow to Critical Intraneuronal Elements Is the Cause

Goldsmith HS.

J Alzheimers Dis. 2022;85(4):1419-1422. doi: 10.3233/JAD-215479.

Comprehensive Review on Neuro-degenerative Type 3 DM

Chandarana CV, Roy S.

Curr Diabetes Rev. 2022;18(8):e131221198790. doi: 10.2174/1573399818666211213103624.

Therapeutic Potential of Ferulic Acid in Alzheimer's Disease

Turkez H, Arslan ME, Barboza JN, Kahraman CY, de Sousa DP, Mardinoğlu A.

Curr Drug Deliv. 2022;19(8):860-873. doi: 10.2174/1567201819666211228153801.

Acute response to cholinergic challenge predicts long-term response to galantamine treatment in patients with Alzheimer's disease

Baakman AC, Gavan C, van Doeselaar L, de Kam M, Broekhuizen K, Bajenaru O, Camps L, Swart EL, Kalisvaart K, Schoonenboom N, Lemstra E, Scheltens P, Cohen A, van Gerven J, Groeneveld GJ.

Br J Clin Pharmacol. 2022 Jun;88(6):2814-2829. doi: 10.1111/bcp.15206. Epub 2022 Jan 26.

The role of brain-derived neurotrophic factor and the neurotrophin receptor p75NTR in age-related brain atrophy and the transition to Alzheimer's disease

Cade S, Zhou XF, Bobrovskaya L.

Rev Neurosci. 2022 Jan 5;33(5):515-529. doi: 10.1515/revneuro-2021-0111. Print 2022 Jul 26.

Imidazole: Multi-targeted Therapeutic Leads for the Management of Alzheimer's Disease

Dhingra AK, Chopra B, Jain A, Chaudhary J.

Mini Rev Med Chem. 2022;22(10):1352-1373. doi: 10.2174/1389557522666220104152141.

Targeting Systemic Innate Immune Cells as a Therapeutic Avenue for Alzheimer Disease

Pons V, Rivest S.

Pharmacol Rev. 2022 Jan;74(1):1-17. doi: 10.1124/pharmrev.121.000400.

Mechanistic and therapeutic implications of EphA-4 receptor tyrosine kinase in the pathogenesis of Alzheimer's disease

Ganguly D, Thomas JA, Ali A, Kumar R.

Eur J Neurosci. 2022 Nov;56(9):5532-5546. doi: 10.1111/ejn.15591. Epub 2022 Jan 13.

The role of serotonin within the microbiota-gut-brain axis in the development of Alzheimer's disease: A narrative review

Aaldijk E, Vermeiren Y.

Ageing Res Rev. 2022 Mar;75:101556. doi: 10.1016/j.arr.2021.101556. Epub 2022 Jan 3.

Progress on the roles of MEF2C in neuropsychiatric diseases

Zhang Z, Zhao Y.

Mol Brain. 2022 Jan 6;15(1):8. doi: 10.1186/s13041-021-00892-6.

Molecular Insights to the Wnt Signaling During Alzheimer's Disorder: a Potential Target for Therapeutic Interventions

Nagu P, Sharma V, Behl T, Pathan AKA, Mehta V.

J Mol Neurosci. 2022 Apr;72(4):679-690. doi: 10.1007/s12031-021-01940-5. Epub 2022 Jan 7.

Vitamin D and Multiple Health Outcomes: An Umbrella Review of Observational Studies, Randomized Controlled Trials, and Mendelian Randomization Studies

Liu D, Meng X, Tian Q, Cao W, Fan X, Wu L, Song M, Meng Q, Wang W, Wang Y.

Adv Nutr. 2022 Aug 1;13(4):1044-1062. doi: 10.1093/advances/nmab142.

Potential innovation against Alzheimer's disorder: a tricomponent combination of natural antioxidants (vitamin E, quercetin, and basil oil) and the development of its intranasal delivery

Karthika C, Appu AP, Akter R, Rahman MH, Tagde P, Ashraf GM, Abdel-Daim MM, Hassan SSU, Abid A, Bungau S.

Environ Sci Pollut Res Int. 2022 Feb;29(8):10950-10965. doi: 10.1007/s11356-021-17830-7. Epub 2022 Jan 9.

Challenge accepted: uncovering the role of rare genetic variants in Alzheimer's disease

Khani M, Gibbons E, Bras J, Guerreiro R.

Mol Neurodegener. 2022 Jan 9;17(1):3. doi: 10.1186/s13024-021-00505-9.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias